{"id":"https://openalex.org/W7202375207","doi":"https://doi.org/10.1186/s41181-026-00513-4","title":"Head-to-head preclinical comparison of a triazine-based SSTR2 homodimer and SSTR2/FAP heterodimer in neuroendocrine tumors","display_name":"Head-to-head preclinical comparison of a triazine-based SSTR2 homodimer and SSTR2/FAP heterodimer in neuroendocrine tumors","publication_year":2026,"publication_date":"2026-11-11","ids":{"openalex":"https://openalex.org/W7202375207","doi":"https://doi.org/10.1186/s41181-026-00513-4"},"language":"en","primary_location":{"id":"doi:10.1186/s41181-026-00513-4","doi":"https://doi.org/10.1186/s41181-026-00513-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s41181-026-00513-4","pdf_url":null,"source":{"id":"https://openalex.org/S3035136591","display_name":"EJNMMI Radiopharmacy and Chemistry","issn_l":"2365-421X","issn":["2365-421X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJNMMI Radiopharmacy and Chemistry","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1186/s41181-026-00513-4","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5147087430","display_name":"Le Li","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Le Li","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5120951710","display_name":"Hanyue Ma","orcid":"https://orcid.org/0009-0009-7307-0388","observed_orcids":["https://orcid.org/0009-0009-7307-0388"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Hanyue Ma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5147103304","display_name":"Dylan Blijleven","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Dylan Blijleven","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109822237","display_name":"Amber Piet","orcid":"https://orcid.org/0009-0002-2328-9313","observed_orcids":["https://orcid.org/0009-0002-2328-9313"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amber Piet","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078854582","display_name":"Corrina de Ridder","orcid":"https://orcid.org/0009-0006-2040-9032","observed_orcids":["https://orcid.org/0009-0006-2040-9032"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Corrina de Ridder","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066411163","display_name":"Debra C. Stuurman","orcid":"https://orcid.org/0000-0003-4923-1312","observed_orcids":["https://orcid.org/0000-0003-4923-1312"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Debra Stuurman","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092645811","display_name":"Priciana Paraiso","orcid":"https://orcid.org/0009-0001-3848-1917","observed_orcids":["https://orcid.org/0009-0001-3848-1917"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Priciana Para\u00efso","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5000473918","display_name":"Yann Seimbille","orcid":"https://orcid.org/0000-0002-9736-5318","observed_orcids":["https://orcid.org/0000-0002-9736-5318"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yann Seimbille","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":2290,"currency":"USD","value_usd":2290},"apc_paid":{"value":2290,"currency":"USD","value_usd":2290},"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.5386000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10754","display_name":"Neuroendocrine Tumor Research Advances","score":0.5386000275611877,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11395","display_name":"Radiopharmaceutical Chemistry and Applications","score":0.4381999969482422,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12505","display_name":"Peptidase Inhibition and Analysis","score":0.009499999694526196,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/somatostatin-receptor-2","display_name":"somatostatin receptor 2","score":0.9580000042915344},{"id":"https://openalex.org/keywords/fibroblast-activation-protein","display_name":"fibroblast activation protein","score":0.890999972820282},{"id":"https://openalex.org/keywords/neuroendocrine-tumors","display_name":"neuroendocrine tumors","score":0.8799999952316284},{"id":"https://openalex.org/keywords/lutetium-177","display_name":"lutetium-177","score":0.9229999780654907},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.777999997138977},{"id":"https://openalex.org/keywords/tissue-distribution","display_name":"tissue distribution","score":0.7919999957084656},{"id":"https://openalex.org/keywords/tumor-targeting","display_name":"tumor targeting","score":0.6940000057220459},{"id":"https://openalex.org/keywords/dual-targeting","display_name":"dual targeting","score":0.5479999780654907},{"id":"https://openalex.org/keywords/receptor-antagonism","display_name":"receptor antagonism","score":0.5239999890327454}],"concepts":[{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.7020000219345093},{"id":"https://openalex.org/C150008808","wikidata":"https://www.wikidata.org/wiki/Q18031731","display_name":"Somatostatin receptor 2","level":4,"score":0.6219000220298767},{"id":"https://openalex.org/C2777807558","wikidata":"https://www.wikidata.org/wiki/Q4914764","display_name":"Biodistribution","level":3,"score":0.5756000280380249},{"id":"https://openalex.org/C204232928","wikidata":"https://www.wikidata.org/wiki/Q899285","display_name":"Immunohistochemistry","level":2,"score":0.5194000005722046},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5073000192642212},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.4722999930381775},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.4526999890804291},{"id":"https://openalex.org/C2779066768","wikidata":"https://www.wikidata.org/wiki/Q1981276","display_name":"Neuroendocrine tumors","level":2,"score":0.40450000762939453},{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.38519999384880066},{"id":"https://openalex.org/C12554922","wikidata":"https://www.wikidata.org/wiki/Q7100","display_name":"Biophysics","level":1,"score":0.38260000944137573},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.37040001153945923},{"id":"https://openalex.org/C139770010","wikidata":"https://www.wikidata.org/wiki/Q1339807","display_name":"Internalization","level":3,"score":0.33730000257492065},{"id":"https://openalex.org/C148898269","wikidata":"https://www.wikidata.org/wiki/Q1108792","display_name":"Kinetics","level":2,"score":0.3287999927997589},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.32510000467300415},{"id":"https://openalex.org/C80115893","wikidata":"https://www.wikidata.org/wiki/Q2067077","display_name":"Somatostatin receptor","level":3,"score":0.32030001282691956},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.31040000915527344},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.304500013589859},{"id":"https://openalex.org/C1491633281","wikidata":"https://www.wikidata.org/wiki/Q7868","display_name":"Cell","level":2,"score":0.2921999990940094},{"id":"https://openalex.org/C13935069","wikidata":"https://www.wikidata.org/wiki/Q2157266","display_name":"Oligopeptide","level":3,"score":0.29190000891685486},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.2831999957561493},{"id":"https://openalex.org/C3020616263","wikidata":"https://www.wikidata.org/wiki/Q1216998","display_name":"Tumor cells","level":2,"score":0.27549999952316284},{"id":"https://openalex.org/C2993559085","wikidata":"https://www.wikidata.org/wiki/Q2126444","display_name":"Radionuclide therapy","level":2,"score":0.271699994802475},{"id":"https://openalex.org/C2777928079","wikidata":"https://www.wikidata.org/wiki/Q2677027","display_name":"Rat\u00f3n","level":2,"score":0.259799987077713},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.258899986743927},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2526000142097473}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1186/s41181-026-00513-4","doi":"https://doi.org/10.1186/s41181-026-00513-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s41181-026-00513-4","pdf_url":null,"source":{"id":"https://openalex.org/S3035136591","display_name":"EJNMMI Radiopharmacy and Chemistry","issn_l":"2365-421X","issn":["2365-421X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJNMMI Radiopharmacy and Chemistry","raw_type":"journal-article"},{"id":"doi:10.21203/rs.3.rs-10620672/v1","doi":"https://doi.org/10.21203/rs.3.rs-10620672/v1","is_oa":true,"landing_page_url":"https://doi.org/10.21203/rs.3.rs-10620672/v1","pdf_url":"https://www.researchsquare.com/article/rs-10620672/latest.pdf","source":{"id":"https://openalex.org/S4306525896","display_name":"Research Square","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Research Square","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1186/s41181-026-00513-4","doi":"https://doi.org/10.1186/s41181-026-00513-4","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s41181-026-00513-4","pdf_url":null,"source":{"id":"https://openalex.org/S3035136591","display_name":"EJNMMI Radiopharmacy and Chemistry","issn_l":"2365-421X","issn":["2365-421X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","norway-1","oarl","poland-20","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319965","host_organization_name":"Springer Nature","host_organization_lineage":["https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Nature"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"EJNMMI Radiopharmacy and Chemistry","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.98580002784729,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320881","display_name":"Universit\u00e4t Heidelberg","ror":"https://ror.org/038t36y30"},{"id":"https://openalex.org/F4320321687","display_name":"Erasmus Medisch Centrum","ror":"https://ror.org/018906e22"},{"id":"https://openalex.org/F4320322725","display_name":"China Scholarship Council","ror":"https://ror.org/04atp4p48"},{"id":"https://openalex.org/F4320326443","display_name":"Nationales Centrum f\u00fcr Tumorerkrankungen Heidelberg","ror":"https://ror.org/01txwsw02"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7202375207.pdf","grobid_xml":"https://content.openalex.org/works/W7202375207.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4405194058","https://openalex.org/W4417457503","https://openalex.org/W2334150321","https://openalex.org/W2972412646","https://openalex.org/W4296363024","https://openalex.org/W4406986078","https://openalex.org/W7161124392","https://openalex.org/W7148734298","https://openalex.org/W7135392549","https://openalex.org/W6992870280"],"abstract_inverted_index":{"Abstract":[0],"Objective":[1],"To":[2],"compare":[3],"the":[4,180,220],"tumor":[5,82,123,172,201,217],"targeting":[6],"and":[7,19,44,53,71,77,95,136,161,187],"pharmacokinetic":[8,212],"properties":[9],"of":[10,183,222],"a":[11,20,36],"SSTR2":[12,96,166],"(somatostatin":[13],"receptor":[14,51],"type":[15],"2)":[16],"homodimer":[17,149,205],"8":[18,150,206],"SSTR2/FAP":[21,223],"(fibroblast":[22],"activation":[23],"protein)":[24],"heterodimer":[25,102,152,168,208],"14":[26,103,153,169,185,209],"for":[27],"neuroendocrine":[28],"tumors.":[29,194],"Methods":[30],"Both":[31,85,196],"dimers":[32,86,120,197],"were":[33,56,62,79],"synthesized":[34],"on":[35,81],"modular":[37],"triazine":[38],"platform":[39],"with":[40,46,148,204],"PEG":[41],"2":[42],"linkers":[43],"labeled":[45],"lutetium-177.":[47],"Radiochemical":[48],"purity,":[49],"lipophilicity,":[50],"affinity,":[52],"cellular":[54],"uptake":[55,108,160,182],"evaluated.":[57],"Ex":[58],"vivo":[59],"biodistribution":[60],"studies":[61],"conducted":[63],"in":[64,109,192],"H69":[65,117,193],"tumor-bearing":[66],"mice":[67],"at":[68],"1,":[69],"4,":[70],"24":[72],"h":[73,127,143],"post-injection":[74],"(p.i.).":[75],"Autoradiography":[76,178],"immunohistochemistry":[78,188],"performed":[80],"sections.":[83],"Results":[84],"showed":[87,104],"high":[88],"radiochemical":[89],"purity":[90],"(>":[91],"95%),":[92],"good":[93],"stability,":[94],"affinity":[97],"similar":[98],"to":[99],"DOTA-TATE.":[100],"The":[101],"approximately":[105],"2-fold":[106],"higher":[107],"FAP-positive":[110],"cells":[111],"than":[112],"[":[113],"177":[114],"Lu]Lu-FAPI-46.":[115],"In":[116],"xenografts,":[118],"both":[119],"demonstrated":[121,179],"comparable":[122,216],"exposure":[124],"(AUC":[125],"0\u221224":[126],"=":[128,141],"98.21":[129],"\u00b1":[130,134],"5.45":[131],"vs.":[132,144],"97.89":[133],"3.50)":[135],"retention":[137],"kinetics":[138],"(t":[139],"1/2":[140],"12.6":[142],"12.9":[145],"h).":[146],"Compared":[147,203],",":[151,186,207],"exhibited":[154,210],"favorable":[155],"pharmacokinetics,":[156],"including":[157],"reduced":[158],"renal":[159],"prolonged":[162],"blood":[163],"circulation.":[164],"Under":[165],"blockade,":[167],"retained":[170],"partial":[171],"uptake,":[173],"suggesting":[174],"additional":[175],"non-SSTR2-mediated":[176],"interactions.":[177],"blockade-resistant":[181],"[\u00b9\u2077\u2077Lu]Lu-":[184],"confirmed":[189],"FAP":[190],"expression":[191],"Conclusion":[195],"achieved":[198],"effective":[199],"SSTR2-mediated":[200],"targeting.":[202],"distinct":[211],"characteristics":[213],"while":[214],"maintaining":[215],"targeting,":[218],"supporting":[219],"feasibility":[221],"dual-targeting.":[224]},"counts_by_year":[],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2026-08-14T00:00:00"}